Corporate Information – Page 11 – Alligator Bioscience

2022-04-05

Regulatory

Notice of annual general meeting in Alligator Bioscience AB

The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedis ...

2022-04-01

Lund, Sweden, April 1, 2022 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced the completion of the patient enrollment for th ...

2022-03-23

Lund, Sweden, March 23, 2022 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced an update on the ongoing OPTIMIZE-1 clinical P ...

2022-03-11

Regulatory

REGULATORY 11 March 2022 Ahead of the Annual General Meeting in Alligator Bioscience AB on May 5, 2022, the Nomination Committee announces i ...

2022-02-042022-03-23

LUND (Sweden) – February 4, 2022 – Alligator Bioscience will host a conference call (in English) for investors, analysts and media on Friday ...

2022-02-01

Lund, Sweden, February 1, 2022 – Alligator Bioscience (Nasdaq Stockholm: ATORX) Alligator Bioscience (Nasdaq Stockholm: ATORX), today announ ...

2022-01-20

Lund, Sweden, January 20, 2021– Alligator Bioscience (Nasdaq Stockholm: ATORX) Alligator Bioscience (Nasdaq Stockholm: ATORX), announces tod ...

2022-01-19

Lund, Sweden, January 19, 2022 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced the initiation a sponsored research collabor ...

2022-01-18

Lund, Sweden, January 18, 2022 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced an update on the on-going OPTIMIZE-1 clinica ...